Medpage Today on MSN8 lá
Holiday Alone Time; Depression Indication for Antipsychotic? Lithium and CKD
People treated with lithium for mood disorders had an increased risk of developing stage 3 or higher chronic kidney disease ...
Managed Healthcare Executive8 lá
Intra-Cellular Therapies Seeks FDA Approval for Caplyta as Additional Treatment for Depression
The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.
Zacks.com on MSN7 lá
ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD
Intra-Cellular Therapies ITCI announced that it has submitted a supplemental new drug application (sNDA) to the FDA aiming to ...